 |
 |
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
1st Conference on the Tear Film and Ocular Surface in Asia
- Room 2 -
- Room 1 -
- Room 2 -
- Room 1 -
- Room 1 -
- Room 2 -
- Room 1 -
- Room 2 -
- Room 1 -
| Date | Monday April 2, 2012 − Wednesday April 4, 2012 |
| Venue | Kenchoji, Kamakura, Japan |
| Official Language | English |
| Contact Detail | 1st Conference on the Tear Film and Ocular Surface in Asia Conference Secretariat 4-1-12-203 Minamiaoyama, Minato-ku, Tokyo 107-0062 JAPAN Tel. +81-3-5775-2075 Fax. +81-3-5775-2076 E-mail. tfos-asia@mediproduce.jp |
 |
Program
April 2, 2012 (1st day) at Shichirigahama Banquet Hall (Kamakura Prince Hotel)
| 18:00-20:00 | Welcome Reception |
April 3, 2012 (2nd day) at Kenchoji Temple
- Room 1 -| 9:30-9:35 | Opening Remarks | |
| Kazuo Tsubota (Japan) | ||
| 9:35-10:00 | Opening Lecture | |
| Kazuo Tsubota (Japan) | ||
| New Challenges for Dry Eye | ||
| 10:00-11:20 | Therapeutic Strategies: Session I | |
| Moderator : Jun Shimazaki (Japan) | ||
| Anthony J. Bron (England) | ||
| Demystifying the Treatment of Dry Eye Disease | ||
| Kyoung Yul Seo (Korea) | ||
| Comparison of Inflammatory Pattern Between Sjögren's and non-Sjögren's Dry Eye Disease | ||
| Shigeru Kinoshita (Japan) | ||
| Regulation of Ocular Surface Inflammation by Ocular Surface Epithelium | ||
| Michael A. Lemp (USA) | ||
| Tear Film Instability in Dry Eye Disease: Clinical Implications | ||
| 11:40-12:40 | Luncheon Seminar Sponsored by Otsuka Pharmaceutical Co., Ltd. | |
| Moderator : Kazuo Tsubota (Japan) | ||
| Tetsuya Kawakita (Japan) | ||
| Lacrimal Gland Regeneration Update | ||
| Scheffer Tseng (USA, via Taiwan) | ||
| Instability of Pre-corneal Tear Film: Hallmark of Dry Eye | ||
| 13:00-14:00 | Therapeutic Strategies: Session II | |
| Moderator : Hitoshi Watanabe (Japan) | ||
| Alessandro Lambiase, presenting for Stefano Bonini (Italy) | ||
| The Nerve Growth Factor: Potential Clinical Applications in Eye Diseases | ||
| Christophe Baudouin (France) | ||
| Rationale for Anti-Inflammatory Strategies in Dry Eye | ||
| Norihiko Yokoi (Japan) | ||
| Clinical Aspects of Short-breakup-time Dry Eye and its Treatment | ||
| 14:00-14:50 | Poster Session & Refreshment Break | |
| 14:50-15:10 | Group Photograph | |
| 15:10-16:50 | Biomarker /Diagnosis | |
| Moderator : Kazuo Tsubota (Japan) | ||
| Penny Asbell (USA) | ||
| Immune Biomarkers in Ocular Surface Disease | ||
| Choun-Ki Joo (Korea) | ||
| Correlations Between Tear Cytokine, Chemokines and Soluble Receptors and Clinical Severity of Dry Eye Disease | ||
| Reiko Arita (Japan) | ||
| Non-invasive Meibography | ||
| Piera Versura (Italy) | ||
| Tear Osmolarity and Dry Eye | ||
| Donald Tan (Singapore) | ||
| High Prevalence and Risk Factors for Meibomian Gland Dysfunction and Dry Eye in 2 Major Asian Ethnic Groups in the Singapore Malay Eye Study and the Singapore Indian Eye Study | ||
| 16:50-18:20 | Evening Seminar Sponsored by Santen Pharmaceutical Co., Ltd. Session 1: Global dry eye epidemiology update |
|
| Moderators : Kazuo Tsubota (Japan), Jun Shimazaki (Japan) | ||
| Debra Schaumberg (USA) | ||
| The Epidemiology of Dry Eye Disease in the United States | ||
| Kazuo Tsubota (Japan) | ||
| Exciting New Findings from “Osaka Study” on Dry Eye | ||
| Session 2: Dry eye clinical conditions and mechanism | ||
| Moderators : Shigeru Kinoshita (Japan), Hitoshi watanabe (Japan) | ||
| David Sullivan (USA) | ||
| New Therapeutic Approaches and Challenges for the Treatment of Dry Eye Disease | ||
| Norihiko Yokoi (Japan) | ||
| Diagnosis and Therapy for Dry Eye Based on Tear Dynamics | ||
| 18:30-20:00 | Dinner Reception |
April 4, 2012 (3rd day) at Kenchoji Temple
| 8:30-8:55 | Zazen (meditation) Practice with English Guidance (optional) | |
| 9:05-9:50 | Morning Seminar Sponsored by Alcon Japan Ltd. Influence of the Preservative in the Medical Treatments |
|
| Moderator : Kensaku Miyake (Japan) | ||
| Norihiko Yokoi (Japan) | ||
| Adverse Effect of Benzalkonium Chloride on the Ocular Surface and Safe Alternatives | ||
| Kensaku Miyake (Japan) | ||
| Pseudophakic Preservative Maculopathy - It’s Up to Dates- | ||
| 10:00-11:40 | Current Treatment & Therapy | |
| Moderator : Anthony J. Bron (England) | ||
| Pinnita Prabhasawat (Thailand) | ||
| Problems of Dry Eye Treatment, Can We Solve Them? | ||
| Yoon Kyung-Chul (Korea) | ||
| Anti-oxidant Treatment in Patients with Dry Eye Disease | ||
| Murat Irkec (Turkey) | ||
| Trends in the Diagnosis and Treatment of Dry Eye in Turkey |
||
| Reynaldo Mananzala Javate (Philippines) | ||
| Retention Rate and Benefits of Painless Punctal Plug | ||
| WITHDRAWN |
||
Dry Eye Syndrome |
||
| 12:00-13:00 | Luncheon Seminar Sponsored by R-Tech Ueno, Ltd. | |
| Moderator : Yoko Ogawa (Japan) | ||
| Stephen Pflugfelder (USA) | ||
| Tear Dysfunction and the Cornea | ||
| 13:20-14:40 | Research Topics | |
| Moderator : Christophe Baudouin (France) | ||
| Zuguo Liu (China) | ||
| The Dry Eye Animal Model Induced by BAK | ||
| Li Wei (China) | ||
| Squamous Metaplasia of the Ocular Surface Epithelium: New Insight of Mechanism and Treatment |
||
| Ray Tsai (Taiwan) | ||
| De-differentiation of Corneal Epithelial Cells in an Altered Basement Membrane after Refractive Surgery |
||
| Pablo Argüeso (USA, via Spain) | ||
| Endomucin: A Novel Regulator of Inflammation | ||
| 14:50-15:35 | Sponsored Session 1 by Novagali Phama SA ( -Room 1- ) New insights into Severe Dry Eye Disease |
|
| Moderator : Murat Dogru (Japan) | ||
| Christophe Baudouin (France) | ||
| Physiopathology and Treatment of Severe Dry Eye Disease | ||
| Michael A. Lemp (USA) | ||
| What Do We Know About Patients with Severe Dry Eye Disease? | ||
| Mourad Amrane (France) | ||
| Cyclosporine Cationic Emulsion for Treatment of Severe Dry Eye Disease | ||
| Sponsored Session 2 by Ora, Inc. ( -Room 2- ) | ||
| Moderator : Mark Abelson (USA) | ||
| Mark Abelson (USA) | ||
| Co-morbidity of Dry Eye and Ocular Allergy | ||
| Shigeaki Ohno (Japan) | ||
| Epidemiology of Allergy | ||
| Paul Gomes (USA) | ||
| Ocular Surface Changes in Allergy and Clinical Models | ||
| George Ousler (USA) | ||
| Ocular Surface Changes in Dry Eye and Clinical Models | ||
| 15:35-15:40 | Closing Remarks | |
| * | Posters must be displayed from April 3 12:00 to April 4 15:00. |
| Page Top |
